arrow
S

Sabrina Katzdobler

german center for neurodegenerative diseases
H指数:15
被引数:861

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic [18F]PI-2620 recording facilitates prediction of β-amyloid positivity and simultaneous staging of tau and neurodegeneration

动态[18F]PI-2620成像有助于预测β-淀粉样蛋白阳性并同步分期tau蛋白和神经退行性病变

2026-09-240
OA
Long-Term Survival of Borna Disease Virus 1 (BoDV-1)-Encephalitis: An Exceptional Case with Valuable Insights for Pathophysiology and Disease Management

博纳病病毒1(BoDV-1)脑炎的长期生存:一个对病理生理学和疾病管理具有重要价值的特殊病例

2026-08-120
OAAI
Feasibility of short imaging protocols for [18F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophy

[18F]氟去甲氧基苯丙胺-D2 PET在自身免疫性脑炎和多系统萎缩中短成像协议的可行性

2026-05-280
OAAI
Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [18F]PI-2620 PET

使用[18F]PI-2620 PET对进行性核上性麻痹中tau聚集的纵向监测

2026-02-240
OAAI
Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer’s disease dementia

早期β-淀粉样蛋白-PET在非阿尔茨海默病痴呆鉴别诊断中的附加价值

2026-02-090
OAAI
A Biomarker-Based Classification of Corticobasal Syndrome

基于生物标志物的皮质基底综合征分类

2025-10-060
OAAI
[18F]fluorodeprenyl-D2 PET can detect and monitor astrogliosis in anti-LGI1-IgG autoimmune encephalitis

[18F]fluorodeprenyl-D2 PET可以检测并监测抗LGI1-IgG自身免疫性脑炎中的星形胶质细胞增生

2025-09-260
OAAI
Enhancing interpretability of AI with radiomics-based deep neural network: proof of concept in the classification of Parkinsonian syndromes with 18F-FDG PET imaging

基于放射组学的深度神经网络提升AI可解释性:在18F-FDG PET成像的帕金森综合征分类中的概念验证

2025-09-110
OAAI
Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's disease

唐氏综合征成年患者血浆蛋白质组谱的探索性分析:阿尔茨海默病背景下的研究

2025-03-200
OAAI
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease

一种定量 Lewy-fold 特异性 α-突触核蛋白种子扩增试验,作为帕金森病的进展标志物

2025-02-200
OA
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies

神经元和少突胶质细胞的tau,而非星形胶质细胞的tau,与原发性tau蛋白病患者体内的tau PET信号相关。

2024-11-240
OA
Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies

结合脑脊液和PI 2620的tau-PET进行基于生物标志物的阿尔茨海默氏病和4r-tau病变分层

2024-09-121
OA
Risk willingness in multiple system atrophy and Parkinson's disease understanding patient preferences
2024-08-150
OAAI
Added value of FDG-PET for detection of progressive supranuclear palsy
2024-08-060
OAAI
Neuroinflammation Parallels 18F-PI-2620 Positron Emission Tomography Patterns in Primary 4-Repeat Tauopathies
2024-07-180
OA
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria

磁共振成像标志物对国际帕金森和运动障碍学会多系统萎缩标准诊断性能的影响

2024-06-072
OA
Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies

皮质下tau与4重复tau病变中连接的皮质区域的灌注不足有关

BRAIN
IF11.7
2024-06-063
PRE
Assessment of [18F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function
2024-05-080
OAAI